Suppr超能文献

SCARB1基因变异与高高密度脂蛋白胆固醇和高脂蛋白(a)合并表型相关。

SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).

作者信息

Yang Xiaoping, Sethi Amar, Yanek Lisa R, Knapper Cathy, Nordestgaard Børge G, Tybjærg-Hansen Anne, Becker Diane M, Mathias Rasika A, Remaley Alan T, Becker Lewis C

机构信息

From the Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD (X.Y., L.R.Y., D.M.B., R.A.M., L.C.B.); Lipoprotein Metabolism Section, Pulmonary and Vascular Medicine Branch, NHLBI, National Institutes of Health, Bethesda, MD (A.S., C.K., A.T.R.); and Copenhagen University Hospital, Faculty of Health Sciences, University of Copenhagen, Denmark (B.G.N., A.T.-H.).

出版信息

Circ Cardiovasc Genet. 2016 Oct;9(5):408-418. doi: 10.1161/CIRCGENETICS.116.001402. Epub 2016 Sep 20.

Abstract

BACKGROUND

SR-B1 (scavenger receptor class B type 1), encoded by the gene SCARB1, is a lipoprotein receptor that binds both high-density lipoprotein (HDL) and low-density lipoprotein. We reported that SR-B1 is also a receptor for lipoprotein (a) (Lp(a)), mediating cellular uptake of Lp(a) in vitro and promoting clearance of Lp(a) in vivo. Although genetic variants in SCARB1 are associated with variations in HDL level, no SCARB1 variants affecting Lp(a) have been reported.

METHODS AND RESULTS

In an index subject with high levels of HDL cholesterol and Lp(a), SCARB1 was sequenced and demonstrated a missense mutation resulting in an S129L substitution in exon 3. To follow up, 2 cohorts (GeneSTAR, the family-based Genetic Study of Atherosclerosis Risk [n=543], and CCHS, the population-based Copenhagen City Heart Study [n=5835]) were screened for combined HDL cholesterol and Lp(a) elevations. Subjects with the extreme phenotype (HDL >80 mg/dL and Lp(a) >100 nmol/L in GeneSTAR, n=8, and >100 mg/dL in CCHS, n=9) underwent sequencing of SCARB1 exons; 15 of 18 from the combined population demonstrated genetic variants, including rare or uncommon missense or splice site mutations in 9 and homozygous synonymous variants in 6. Functional studies with 4 of the SCARB1 variants (c.386C>T, c.631-14T>G, c.4G>A, and c.631-53C>T & c.726+55CG>CA) showed decreased receptor function in vitro.

CONCLUSIONS

Human SCARB1 gene variants are associated with a new lipid phenotype, characterized by high levels of both HDL cholesterol and Lp(a). SCARB1 exonic variants often result in diminished function of translated SR-B1 via reduced binding/intracellular transport of Lp(a).

摘要

背景

由SCARB1基因编码的B1类清道夫受体(SR-B1)是一种脂蛋白受体,可与高密度脂蛋白(HDL)和低密度脂蛋白结合。我们曾报道,SR-B1也是脂蛋白(a)[Lp(a)]的受体,在体外介导Lp(a)的细胞摄取,并在体内促进Lp(a)的清除。尽管SCARB1中的基因变异与HDL水平的变化有关,但尚未报道有影响Lp(a)的SCARB1变异。

方法与结果

在一名HDL胆固醇和Lp(a)水平均较高的索引受试者中,对SCARB1进行测序,结果显示存在一个错义突变,导致外显子3中的S129L替换。为了进行后续研究,对2个队列(基因STAR,基于家系的动脉粥样硬化风险遗传研究[n = 543],以及CCHS,基于人群的哥本哈根城市心脏研究[n = 5835])进行了HDL胆固醇和Lp(a)升高的联合筛查。具有极端表型(基因STAR中HDL>80 mg/dL且Lp(a)>100 nmol/L,n = 8;CCHS中HDL>100 mg/dL,n = 9)的受试者接受了SCARB1外显子的测序;联合人群中的18名受试者中有15名显示出基因变异,包括9名罕见或不常见的错义或剪接位点突变,以及6名纯合同义变异。对4种SCARB1变异(c.386C>T、c.631-14T>G、c.4G>A和c.631-53C>T & c.726+55CG>CA)进行的功能研究表明,其体外受体功能降低。

结论

人类SCARB1基因变异与一种新的脂质表型相关,其特征是HDL胆固醇和Lp(a)水平均较高。SCARB1外显子变异通常会通过减少Lp(a)的结合/细胞内转运,导致翻译后的SR-B1功能减弱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验